Conclusion

We hope this sourcebook gives you some practical guidance on some areas of compliance, and where to go for more advice when working together with patients and patient organisations.

While the core principles of behaviour should remain fairly constant, this is a developing area with new information and updates continuing to emerge. We will aim to update the sourcebook regularly and would appreciate any comments and feedback.

As a reminder, while this new sourcebook provides informal guidance, following it does not guarantee compliance. Companies need to ensure they comply with the 魅影直播 Code.

Further information and sources

魅影直播:
Code of Practice

魅影直播/National Voices:

Association of Medical Research Charities:

EFPIA:

IFPMA:

Patient Focused Medicines Development, Workgroup of European Patient Advocacy Networks, Myeloma Patients Europe:

European Respiratory Journal:

Innovative Medicines Initiative:

Change Foundation:
Should Money Come Into It? (no longer available online)

Acknowledgements

We would like to thank the following organisations for their help and contributions in developing this guidance:

Bristol Myers Squibb
Eli Lilly
Gilead
Grunenthal
Janssen-Cilag
MSD
Napp
Novo Nordisk
Sanofi
Sunovion
Teva
UCB
EFPIA
AMRC
Arthritis UK
Asthma UK
British Lung Foundation
Cancer 52
Cystic Fibrosis
Diabetes UK
Haemophilia UK
Heart Rhythm Alliance
Kidney Research UK
MPS Society
MS Society
National Voices
NCRI
NIHR INVOLVE
Pain UK
Parkinsons UK
Primary Care Rheumatology & Musculoskeletal Medicine Society
UK Gout Society

How to get in touch

魅影直播:

魅影直播 Head Office
7th floor, Southside
105 Victoria Street
London
SW1E 6QT

Telephone: +44 (0) 20 7930 3477
Email: getintouch@abpi.org.uk
/

PMCPA:

7th floor, Southside
105 Victoria Street
London
SW1E 6QT

Telephone: +44 (0) 7747 8880

Complaints should be submitted to the聽Director of the PMCPA at the above address,聽email complaints@pmcpa.org.uk.

魅影直播